AgomAb Therapeutics NV
Ownership
Ownership Structure
Who owns AgomAb Therapeutics NV (AGMB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 23.3% of the shares are freely tradable; institutional investors hold 49.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| EQT Fund Management S.à r.l. | 10.44 | 5,141,992 | +0.0 | 06/30/2026 |
| Sanofi | 5.65 | 2,783,096 | +0.0 | 06/30/2026 |
| Redmile Group, LLC | 5.55 | 2,733,926 | +1,649.7 | 06/30/2026 |
| Cormorant Asset Management, LLC | 5.01 | 2,465,348 | +0.0 | 03/31/2026 |
| TCG Crossover Management, LLC | 4.17 | 2,053,233 | +0.0 | 06/30/2026 |
| Federated Hermes Inc | 3.29 | 1,618,000 | +0.0 | 06/30/2026 |
| Casdin Capital, LLC | 3.15 | 1,550,000 | +0.0 | 06/30/2026 |
| Andera Partners | 3.12 | 1,538,702 | +0.0 | 06/30/2026 |
| FMR Inc | 2.96 | 1,458,677 | +0.0 | 03/31/2026 |
| Nantahala Capital Management, LLC | 2.44 | 1,200,000 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.